In our study, we found for the first time that berberine can inhibit the Warburg effect of ovarian cancer cells, and berberine increased the expression of miR-145 by promoting the expression of TET3 and reducing the methylation level of the promoter region of miR-145 precursor gene. Here, TET3 is linked to ovarian carcinoma.